Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):821-8. doi: 10.1016/j.ijrobp.2011.08.020. Epub 2011 Dec 28.
To report our institution's experience using prone positioning for three-dimensional conformal radiotherapy (3D-CRT) to deliver post-lumpectomy whole breast irradiation (WBI) in a cohort of women with large and/or pendulous breasts, to determine the rate of acute and late toxicities and, more specifically, cosmetic outcomes. We hypothesized that using 3D-CRT for WBI in the prone position would reduce or eliminate patient and breast size as negative prognostic indicators for toxicities associated with WBI.
From 1998 to 2006, 110 cases were treated with prone WBI using 3D-CRT. The lumpectomy, breast target volumes, heart, and lung were contoured on all computed tomography scans. A dose of 45-50 Gy was prescribed to the breast volume using standard fractionation schemes. The planning goals were ≥95% of prescription to 95% of the breast volume, and 100% of boost dose to 95% of lumpectomy planning target volume. Toxicities and cosmesis were prospectively scored using the Common Terminology Criteria for Adverse Effects Version 3.0 and the Harvard Scale. The median follow-up was 40 months.
The median body mass index (BMI) was 33.6 kg/m(2), and median breast volume was 1396 cm(3). The worst toxicity encountered during radiation was Grade 3 dermatitis in 5% of our patient population. Moist desquamation occurred in 16% of patients, with only 2% of patients with moist desquamation outside the inframammary/axillary folds. Eleven percent of patients had Grade ≥2 late toxicities, including Grade 3 induration/fibrosis in 2%. Excellent to good cosmesis was achieved in 89%. Higher BMI was associated with moist desquamation and breast pain, but BMI and breast volume did not impact fibrosis or excellent to good cosmesis.
In patients with higher BMI and/or large-pendulous breasts, delivering prone WBI using 3D-CRT results in favorable toxicity profiles and high excellent to good cosmesis rates. Higher BMI was associated with moist desquamation, but prone positioning removed BMI and breast size as factors for poorer cosmetic outcomes. This series adds to the growing literature demonstrating that prone WBI may be advantageous in select patients.
报告我们机构在一组大乳房或乳房下垂的女性中使用俯卧位三维适形放疗(3D-CRT)进行保乳术后全乳房照射(WBI)的经验,以确定急性和迟发性毒性的发生率,更具体地说,是美容结果。我们假设在俯卧位使用 3D-CRT 进行 WBI 将减少或消除患者和乳房大小作为与 WBI 相关毒性的负预后指标。
1998 年至 2006 年,110 例患者采用 3D-CRT 行俯卧位 WBI 治疗。在所有 CT 扫描上对乳房切除术、乳房靶区、心脏和肺进行轮廓勾画。采用标准分割方案,将 45-50 Gy 的剂量处方至乳房体积。计划目标是将 95%的处方剂量给到 95%的乳房体积,将 100%的 boost 剂量给到 95%的乳房切除术计划靶区。采用通用不良事件术语标准 3.0 版和哈佛量表对毒性和美容效果进行前瞻性评分。中位随访时间为 40 个月。
中位体重指数(BMI)为 33.6kg/m2,中位乳房体积为 1396cm3。在放射治疗过程中最严重的毒性是 5%的患者出现 3 级皮炎。16%的患者发生湿性脱皮,仅有 2%的患者在乳晕/腋窝褶皱外发生湿性脱皮。11%的患者发生≥2 级迟发性毒性,包括 2%的患者发生 3 级硬结/纤维化。89%的患者获得了优秀到良好的美容效果。较高的 BMI 与湿性脱皮和乳房疼痛有关,但 BMI 和乳房体积并不影响纤维化或优秀到良好的美容效果。
在 BMI 较高和/或乳房较大下垂的患者中,使用 3D-CRT 进行俯卧位 WBI 可获得良好的毒性谱和较高的优秀到良好美容效果率。较高的 BMI 与湿性脱皮有关,但俯卧位将 BMI 和乳房大小作为较差美容效果的因素去除。本系列研究增加了越来越多的文献,表明俯卧位 WBI 可能对某些患者有利。